20:07 , Aug 15, 2019 |  BC Innovations  |  Distillery Techniques

Mutation combination as endometrial cancer biomarker

TECHNIQUES CATEGORY: Biomarkers TECHNOLOGY: Gene profiling; tissue markers; SNPs Michigan State University and Van Andel Institute researchers have linked a combination of two mutations -- a loss-of-function mutation in tumor suppressor ARID1A plus an activating...
00:13 , Aug 9, 2019 |  BC Extra  |  Preclinical News

Aug. 8 Preclinical Quick Takes: Mayo Clinic assay for residual disease; plus camouflage for bacterial agents, Elicio's KRAS vaccine and more

Mayo Clinic liquid biopsy identifies breast cancer residual disease  A Mayo Clinic team reported in a Science Translational Medicine article that a personalized multiplex sequencing approach called TARDIS (targeted digital sequencing) could accurately distinguish pathological...